<div id="readability-page-1">RedHill Biopharma (RDHL) has regained compliance with Nasdaq as confirmed by Nasdaq on November 26, 2025. More on RedHill     Seeking Alpha’s Quant Rating on RedHill   Financial information for RedHill</div>

Redhill生物制藥

<p>RedHill 生物製藥（RDHL）已於 2025 年 11 月 26 日確認重新符合納斯達克的合規要求。更多關於 RedHill 的信息請查看 Seeking Alpha 對 RedHill 的量化評級及其財務信息</p>

RedHill 生物製藥重新符合納斯達克股東權益合規要求